BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7350733)

  • 21. Tubulointerstitial injury: early or late event in the pathogenesis of hypertensive nephropathy?
    Tylicki L; Rutkowki B
    Kidney Int; 2004 May; 65(5):1971-2; author reply 1972. PubMed ID: 15086947
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gout and hyperuricemia associated with lead poisoning].
    Lejeune E; Tolot F; Meunier P
    Rev Rhum Mal Osteoartic; 1969 Apr; 36(4):161-73. PubMed ID: 5402943
    [No Abstract]   [Full Text] [Related]  

  • 23. Giant cell tubulitis with tubular basement membrane immune deposits: a report of two cases after cardiac valve replacement surgery.
    Chang A; Peutz-Kootstra CJ; Kowalewska J; Logar CM; Gitomer JJ; Davis CL; Shankland SJ; Alpers CE; Smith KD
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):920-4. PubMed ID: 17699308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I; Krzymański M
    Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor.
    Choi YJ; Chakraborty S; Nguyen V; Nguyen C; Kim BK; Shim SI; Suki WN; Truong LD
    Hum Pathol; 2000 Dec; 31(12):1491-7. PubMed ID: 11150374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-associated nephropathy. Part II: Tubulo-interstitial lesions. A: Acute interstitial nephritis, nephrotoxic lesions, analgesic nephropathy.
    Laberke HG
    Curr Top Pathol; 1980; 69():184-215. PubMed ID: 7238127
    [No Abstract]   [Full Text] [Related]  

  • 27. Tubulointerstitial diseases.
    Braden GL; O'Shea MH; Mulhern JG
    Am J Kidney Dis; 2005 Sep; 46(3):560-72. PubMed ID: 16129220
    [No Abstract]   [Full Text] [Related]  

  • 28. Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria.
    Toblli JE; Ferder L; Stella I; Angerosa M; Inserra F
    J Urol; 2001 Jul; 166(1):275-80. PubMed ID: 11435885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of tubular interstitial nephritis.
    Tanaka T; Nangaku M
    Contrib Nephrol; 2011; 169():297-310. PubMed ID: 21252528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Karyomegalic tubulointerstitial nephritis--a case report.
    Baba F; Nanovic L; Jaffery JB; Friedl A
    Pathol Res Pract; 2006; 202(7):555-9. PubMed ID: 16678356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypokalemic flaccid paralysis as the presenting symptom of autoimmune interstitial nephropathy.
    Nakhoul F; Plavnic Y; Lichtig H; Better OS
    Isr J Med Sci; 1993 May; 29(5):300-3. PubMed ID: 8314692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case report. Severe hyperuricemia, hypokalemic alkalosis and tubulointersitial nephritis.
    Kraikitpanitch S; Lindeman RD; Mandal AK
    Am J Med Sci; 1976; 271(1):77-83. PubMed ID: 1258899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.
    Zaidan M; Lescure FX; Brochériou I; Dettwiler S; Guiard-Schmid JB; Pacanowski J; Rondeau E; Pialoux G; Girard PM; Ronco P; Plaisier E
    Clin J Am Soc Nephrol; 2013 Jun; 8(6):930-8. PubMed ID: 23430209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].
    Jungers P; Joly D; Blanchard A; Courbebaisse M; Knebelmann B; Daudon M
    Nephrol Ther; 2008 Jul; 4(4):231-55. PubMed ID: 18499551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis.
    Mori Y; Kishimoto N; Yamahara H; Kijima Y; Nose A; Uchiyama-Tanaka Y; Fukui M; Kitamura T; Tokoro T; Masaki H; Nagata T; Umeda Y; Nishikawa M; Iwasaka T
    Clin Exp Nephrol; 2005 Mar; 9(1):79-84. PubMed ID: 15830279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: evidence for a role for insulin-like growth factor I.
    Hirschberg R
    J Clin Invest; 1996 Jul; 98(1):116-24. PubMed ID: 8690782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal microvascular disease in an aging population: a reversible process?
    Futrakul N; Futrakul P
    Ren Fail; 2008; 30(4):353-6. PubMed ID: 18569906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potassium wasting and other renal tubular defects with rifampin nephrotoxicity.
    Cheng JT; Kahn T
    Am J Nephrol; 1984; 4(6):379-82. PubMed ID: 6517118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis.
    Lino M; Binaut R; Noël LH; Patey N; Rustin P; Daniel L; Serpaggi J; Varaut A; Vanhille P; Knebelmann B; Grünfeld JP; Fakhouri F
    Am J Kidney Dis; 2005 Sep; 46(3):e41-6. PubMed ID: 16129198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipids--what is the evidence for their role in progressive renal disease?
    Wheeler DC
    Nephrol Dial Transplant; 1995; 10(1):14-6. PubMed ID: 7724016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.